Hello, we are Uplift…
and we make nice things.
Lorem ipsum dolor sit amet isse potenti. Vesquam ante aliquet lacusemper elit. Cras neque nulla, convallis non commodo et, euismod nonsese. At vero eos et accus amus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non volup tatum deleniti atque corrupti quo.
John A. Zebala, MD, PhD
President and CEO
MD and PhD (Molecular Biology) from Weill Cornell Medical School. Syntrix founder and architect of the company and its development strategy.
View Profile
Stuart Kahn, MD
Medical Director
Clinical trial management; >10 years with company
MD from University of Medicine and Dentistry of New Jersey
Dean Y. Maeda, PhD
– Director Medicinal Chemistry and Preclinical Development
Management of preclinical development programs; >10 years with company
PhD (Pharmaceutical Chemistry) from Oregon State University
Mark Mendel, PhD
Board Member*
Senior Consultant, Broadmark Capital LLC
Previously Co-Founder and Managing Director of RiverVest Venture Partners and Kauffman Fellow at ARCH Venture Partners
Venture investor in Conforma Therapeutics, Xcyte Therapies, and CGI Pharmaceuticals
PhD (Bioengineering) from U Pennsylvania
Larry Fritz, PhD
Board Member*
Founder and CEO Incro Pharmaceuticals (recently acquired by Denali Therapeutics)
Previously Founder and CEO at Covella Pharmaceuticals, Conforma Therapeutics and Cabrellis Pharmaceuticals, as well as Scientific Founder of Athena Neurosciences, IDUN Pharmaceuticals—all successfully sold.
PhD (Biophysics) Rockefeller University
Martin “Mac” Cheever, MD
Fred Hutchinson Cancer Center
Principal Investigator of the National Cancer Institute-funded Cancer Immunotherapy Trials Network.
View Profile